A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)
Status:
Terminated
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
One objective of this study is to determine the levels of markers of inflammation on the
eyelid margin of subjects with blepharoconjunctivitis and compare them with those of healthy
volunteers. Another objective is to determine in subjects with blepharoconjunctivitis the
effect of azithromycin ophthalmic solution, 1 % on markers of inflammation of lid margins and
conjunctivae and on signs and symptoms of blepharoconjunctivitis.